Method and system for characterization and mapping of tissue lesions

Abstract

The present invention provides a method and an apparatus for the in vivo, non-invasive, early detection of alterations and mapping of the grade of these alterations, caused in the biochemical and/or in the functional characteristics of epithelial tissues during the development of tissue atypias, dysplasias, neoplasias and cancers. The method is based, at least in part, on the simultaneous measurement of the spatial, temporal and spectral alterations in the characteristics of the light that is re-emitted from the tissue under examination, as a result of a combined tissue excitation with light and special chemical agents. The topical or systematic administration of these agents result in an evanescent contrast enhancement between normal and abnormal areas of tissue. The apparatus enables the capturing of temporally successive imaging in one or more spectral bands simultaneously. Based on the measured data, the characteristic curves that express the agent-tissue interaction kinetics, as well as numerical parameters derived from these data, are determined in any spatial point of the examined area. Mapping and characterization of the lesion, are based on these parameters.

Description

RELATED APPLICATIONS [0001] This application is a continuation application of application Ser. No. 10 / 346,338, filed on Jan. 16, 2003, pending, which is a continuation of 09 / 739,089, filed on Dec. 15, 2000, pending, which in turn claims priority to Greek National Application Serial No. 20000 / 00102 filed on Mar. 28, 2000 and U.S. provisional Application No. ______, entitled “Method And Apparatus For Amplifying Pathological Features In Tissues”, filed on Dec. 15, 1999. The contents of all of the aforementioned application(s) are hereby incorporated by reference.FIELD OF THE INVENTION [0002] The present invention is directed to a method and apparatus for the in vivo, non invasive detection and mapping of the biochemical and / or functional pathologic alterations of human tissues. BACKGROUND OF THE INVENTION [0003] Cancer precursors signs are the so called pre-cancerous states, which are curable if they are detected at an early stage. In the opposite case the lesion can progress in depth,...

AI Technical Summary

Benefits of technology

[0047] In a further embodiment, in the case of microscopes used in clinical diagnostic examinations, surgical microscopes and colposcopes, comprise an articulated arm onto which the optical head is attached, which optical head comprises an objective lens, focusing optics, a mechanism for selecting the magnification, an eyepiece, a mount for attaching a camera, an illuminator and two linear polarizers, where the two linear polarizers are attached, one at a point along the optical path of the illuminating light beam and the other at a point along the optical path of the rays that form the image of the tissue, with the capability of rotating the polarization planes of these light polarizing optical elements, so that when these planes are perpendicular to each other, the contribution of the tissue's surface reflect

Problems solved by technology

In the opposite case the lesion can progress in depth, resulting in the development of invasive cancer and metastases.

At this stage, the possibilities of successful therapy are dramatically diminished.

The conventional clinical process of optical examination have very limited capabilities in detecting cancerous and pre-cancerous tissue lesions.

However, biopsy sampling poses several problems, such as: a) risk for sampling errors associated with the visual limitations in detecting and localizing suspicious areas; b) biopsy can alter the natural history of the intraepithelial lesion; c) mapping and monitoring of the lesion require multiple tissue sampling, which is subjected to several risks and limitations; d) the diagnostic procedure performed with biopsy sampling and histologic evaluation is qualitative, subjective, time consuming, costly and labor intensive.

The main disadvantage of fluorescence spectroscopy is that the existing biochemical modifications associated with the progress of the disease are not manifested in a direct way as modifications in the measured fluorescence spectra.

In other words the spectra carry convoluted information for several components and therefore it is difficult assess alterations in tissue features of diagnostic importance; and b) The spectra are broad due to the fact that a large number of tissue components are optically excited and contribute to the captured optical signal.

As a result the spectra do not carry specific information for the pathologic alterations and thus they are of limited diagnostic value.

The last has the capability of providing more analytical information, it requires however complex instrumentation and ideal experimental conditions, which substantially hinder their clinical use.

It is generally known that tissues are characterized by the lack of spatial homogeneity and consequently the spectral analysis of distributed spatial points is insufficient for the characterization of their status.

However, due to the insignificance of the spectral differences between normal and pathologic tissue, which is in general the case, inspection in narrow spectral bands does not allow the highlighting of these characteristics and even more so, the identification and staging of the pathologic area.

Furthermore, in several cases of early pathologic conditions, the phenomenon of temporary staining after administering the agent, is short-lasting and thus the examiner is not ab

Images